Estrogen and neurodegeneration
- PMID: 12737524
- DOI: 10.1023/a:1023246921127
Estrogen and neurodegeneration
Abstract
Although estrogen is best known for its effects on the maturation and differentiation of the primary and secondary sex organs, increasing evidence suggests that its influence extends beyond this system, and its activity in the CNS may initiate, or influence our susceptibility to neurodegenerative decline. Estrogen has been proposed to act as a neuroprotectant at several levels, and it is probable that deprivation of estrogen as a result of menopause exposes the aging or diseased brain to several insults. In addition, estrogen deprivation is likely to initiate or enhance degenerative changes caused by oxidative stress, and to reduce the brain's ability to maintain synaptic connectivity and cholinergic integrity leading to the cognitive decline seen in aged and disease-afflicted individuals.
Similar articles
-
Neuroprotective effects of estrogens: potential mechanisms of action.Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):347-58. doi: 10.1016/s0736-5748(00)00017-4. Int J Dev Neurosci. 2000. PMID: 10817919 Review.
-
Oestrogen as a neuroprotective hormone.Nat Rev Neurosci. 2002 Jun;3(6):433-42. doi: 10.1038/nrn846. Nat Rev Neurosci. 2002. PMID: 12042878 Review.
-
Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?Curr Aging Sci. 2010 Jul;3(2):113-26. doi: 10.2174/1874609811003020113. Curr Aging Sci. 2010. PMID: 20167003 Review.
-
Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.Steroids. 2007 May;72(5):381-405. doi: 10.1016/j.steroids.2007.02.003. Epub 2007 Feb 21. Steroids. 2007. PMID: 17379265 Free PMC article. Review.
-
Neuroprotective activities of estrogen: an update.J Neurocytol. 2000 May-Jun;29(5-6):351-8. doi: 10.1023/a:1007109222673. J Neurocytol. 2000. PMID: 11424951 Review.
Cited by
-
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.J Neurol. 2004 Oct;251(10):1208-14. doi: 10.1007/s00415-004-0508-y. J Neurol. 2004. PMID: 15503099
-
Gender, sex steroid hormones, and Alzheimer's disease.Horm Behav. 2013 Feb;63(2):301-7. doi: 10.1016/j.yhbeh.2012.04.006. Epub 2012 Apr 19. Horm Behav. 2013. PMID: 22554955 Free PMC article. Review.
-
Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE {varepsilon}4 carriers: a case-control study.BMJ Open. 2013 Sep 18;3(9):e003200. doi: 10.1136/bmjopen-2013-003200. BMJ Open. 2013. PMID: 24052609 Free PMC article.
-
The APOE4 genotype alters the response of microglia and macrophages to 17beta-estradiol.Neurobiol Aging. 2008 Dec;29(12):1783-94. doi: 10.1016/j.neurobiolaging.2007.04.018. Epub 2007 Jun 5. Neurobiol Aging. 2008. PMID: 17553597 Free PMC article.
-
Sex-related and tissue-specific effects of tobacco smoking on brain atrophy: assessment in a large longitudinal cohort of healthy elderly.Front Aging Neurosci. 2014 Nov 3;6:299. doi: 10.3389/fnagi.2014.00299. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25404916 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical